TET2 and kidney cancer: By using siRNAs targeting all three TETs, expression of CTSD and CLN3 was shown to be specifically repressed by TET2 in MCF-7 and T47D breast cancer cells and, to a lower extent, in HEK293T kidney cancer cells (Fig S4D).